China SXT Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Taizhou
SXTC chart
What traders are saying about $SXTC
Latest postsChina SXT Pharmaceuticals, Inc. news
- Asset turnover of China Sxt Pharmaceuticals, Inc. Class A – FWB:2RY3
TradingView ·
- China SXT Pharmaceuticals, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (SXTC)
Traders Union ·
- Short Interest Alert: Most and least shorted sub-$2B healthcare stock at the end of October
Seeking Alpha ·
- China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Yahoo Finance ·
- China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
Yahoo Finance ·
- BC-Most Active Stocks
Yahoo Finance ·
- Univest Securities, LLC Announces Closing of $12 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
Yahoo Finance ·
- China SXT Pharmaceuticals Announces $12 Million Registered Direct Offering With Significant Dilution Potential
investorshub.advfn.com ·
- China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
Yahoo Finance ·
- Univest Securities, LLC Announces Closing of $9 Million Registered Direct Offering for its Client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
Yahoo Finance ·
- China SXT Pharmaceuticals Inc. Announces $9 Million Registered Direct Offering
Yahoo Finance ·
- China SXT Pharmaceuticals, Inc. Announces Share Re-classification
Yahoo Finance ·
China SXT Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $1.9M | $2.0M |
| Net income | -$6.2M | -$3.3M | -$3.1M | -$5.9M |
| Diluted EPS | $-9.13 | $-348.17 | $-4285.66 | $-177.84 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 20-FANNUAL REPORT
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About China SXT Pharmaceuticals, Inc.
- Ticker
- SXTC (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Taizhou
- Incorporated in
- Virgin Islands, British
- Fiscal year end
- March 31
- SEC CIK
- 1723980
Frequently asked questions
What exchange is China SXT Pharmaceuticals, Inc. listed on?
China SXT Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SXTC.
What industry is China SXT Pharmaceuticals, Inc. in?
China SXT Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is China SXT Pharmaceuticals, Inc. headquartered?
China SXT Pharmaceuticals, Inc.'s business address on file with the SEC is in Taizhou.
When does China SXT Pharmaceuticals, Inc.'s fiscal year end?
China SXT Pharmaceuticals, Inc.'s fiscal year ends on March 31.
How much revenue did China SXT Pharmaceuticals, Inc. report?
China SXT Pharmaceuticals, Inc. reported $1.9M in revenue for calendar year 2023, according to its SEC filings.